Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 272

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Stage IV sarcoidosis: comparison of survival with the general population and causes of death

Open access
Nardi, A., Brillet, P-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J-M., Valeyre, D., Nunes, H. · 2011 · European Respiratory Journal

Abstract

The objectives of this study were to compare the survival of sarcoid patients with pulmonary fibrosis with that of the general population and to determine the causes of death and the incidence of evolutive complications. This retrospective cohort included 142 sarcoid patients in radiographic stage IV (74 males; mean±sd age 48.1±12 yrs). Their survival was compared with that of the general French population, matched for the year and age at diagnosis of stage IV disease, sex and length of follow-up. Expected survival probabilities were calculated year-by-year on the basis of probabilities provided by official demographic data for France. Survival curves were based on the Kaplan–Meier method and compared using the log-rank test. During the follow-up period (7.1±4.8 yrs), pulmonary hypertension (PH) was observed in 29.7% of cases and aspergilloma in 11.3%. Long-term oxygen therapy was required in 12%. Survival was 84.1% at 10 yrs, which was worse than for the general population (p=0.013). 16 (11.3%) patients died from the following causes: refractory PH (n=5), chronic respiratory insufficiency (n=4), acute respiratory insufficiency (n=2), haemoptysis due to aspergilloma (n=1), heart sarcoidosis (n=1), nocardiosis (n=1) and unknown causes (n=2). Survival is significantly decreased in stage IV patients. 75% of fatalities are directly attributable to respiratory causes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00187410

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 272

Metadata

Authors
Nardi, A., Brillet, P.-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J.-M., Valeyre, D., & Nunes, H.
Venue
European Respiratory Journal
Published
2011-11-10
Volume
38
Issue
6
Pages
1368-1373
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2145323940
Cited by
272
References
30
FWCI
6.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stage IV sarcoidosis: comparison of survival with the general population and causes of death. https://app.cochat.ai/papers/10.1183/09031936.00187410
The paper
Nardi, A., Brillet, P.-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J.-M., Valeyre, D., & Nunes, H. (2011). Stage IV sarcoidosis: comparison of survival with the general population and causes of death. European Respiratory Journal. https://doi.org/10.1183/09031936.00187410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.